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Objective
Optimization of AIS management necessitates early and
accurate identification of progressive deformities. As
standard radiographic evaluation relies on variables that
change over time, these methods are often inaccurate in
assessing risk of progression. Most data suggest that ado-
lescent idiopathic scoliosis (AIS) has a polygenic inherit-
ance. The exact gene(s) involved, however, have not been
identified. Using our unique genealogy resources and a
large patient population from across the United States, we
hope to discover the molecular basis of AIS. As an interim
result in our efforts to understand the genetic basis of AIS,
we report on twelve DNA markers potentially useful in
accurately predicting curve progression.
Methods
DNA samples from 675 skeletally mature AIS subjects
were collected from spine centers across the U.S. Radio-
graphic data at initial presentation during adolescence
and at skeletal maturity allowed identification of surgical
curves (progression beyond 40 degrees Cobb). Genotypes
were obtained for twelve DNA markers identified as hav-
ing diagnostic utility in AIS. Genotype weighting factors
were established in an independent discovery sample set.
Clinical risk scores were estimated using the subject's first
radiographic evaluation for AIS. Using an additive model,
summed risk scores were used to classify subjects as either
LOW or HIGH risk for progression to a surgical curve.
Results
Of 675 subjects with AIS, 454 progressed to a surgical
curve (>40 degrees), with 187 and 34, respectively, main-
taining mild (<25 degrees) and moderate (25–40 degrees)
curves. Using the additive model, 181/187 (97%) of sub-
jects with mild curves were correctly classified as LOW risk
and 416/454 (92%) as HIGH risk for progression to a sur-
gical curve (p < 0.00001).
Conclusion
The twelve DNA markers discovered in this study will
greatly improve our ability to assess risk of progression.
For HIGH risk patients this will likely result in earlier brac-
ing or fusionless scoliosis surgery. For LOW risk patients
this will allow elimination of years of unnecessary obser-
vation. When compared to standard radiographic meth-
ods, the twelve DNA markers identified in this study
provide a superior assessment of risk of progression in
AIS. Additional research will likely refine this marker
panel and further improve our ability to accurately predict
AIS progression.
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